Envestnet Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-15,175
| Closed | -$2.51M | – | 3817 |
|
|
2021
Q2 | $2.51M | Sell |
15,175
-528
| -3% | -$88.1K | ﹤0.01% | 1917 |
|
|
2021
Q1 | $2.41M | Buy |
15,703
+1,520
| +11% | +$206K | ﹤0.01% | 1831 |
|
|
2020
Q4 | $1.78M | Buy |
14,183
+3,413
| +32% | +$382K | ﹤0.01% | 1828 |
|
|
2020
Q3 | $1.09M | Sell |
10,770
-150
| -1% | -$15.3K | ﹤0.01% | 1966 |
|
|
2020
Q2 | $1.06M | Sell |
10,920
-4,325
| -28% | -$402K | ﹤0.01% | 1930 |
|
|
2020
Q1 | $1.27M | Sell |
15,245
-13,413
| -47% | -$1.31M | ﹤0.01% | 1679 |
|
|
2019
Q4 | $3.19M | Buy |
28,658
+17,739
| +162% | +$1.82M | ﹤0.01% | 1355 |
|
|
2019
Q3 | $1.08M | Buy |
10,919
+1,383
| +15% | +$137K | ﹤0.01% | 1894 |
|
|
2019
Q2 | $945K | Buy |
9,536
+150
| +2% | +$14.3K | ﹤0.01% | 1977 |
|
|
2019
Q1 | $1.03M | Sell |
9,386
-59
| -0.6% | -$6.17K | ﹤0.01% | 1890 |
|
|
2018
Q4 | $869K | Buy |
+9,445
| New | +$956K | ﹤0.01% | 1827 |
|
|
2018
Q3 | – | Sell |
-1,817
| Closed | -$170K | – | 2888 |
|
|
2018
Q2 | $170K | Sell |
1,817
-20
| -1% | -$1.72K | ﹤0.01% | 1745 |
|
|
2018
Q1 | $152K | Sell |
1,837
-41
| -2% | -$3.64K | ﹤0.01% | 1741 |
|
|
2017
Q4 | $171K | Buy |
1,878
+55
| +3% | +$4.58K | ﹤0.01% | 1909 |
|
|
2017
Q3 | $139K | Buy |
1,823
+26
| +1% | +$1.97K | ﹤0.01% | 1970 |
|
|
2017
Q2 | $135K | Sell |
1,797
-47
| -3% | -$3.26K | ﹤0.01% | 2026 |
|
|
2017
Q1 | $121K | Buy |
1,844
+1,289
| +232% | +$75.9K | ﹤0.01% | 2120 |
|
|
2016
Q4 | $30K | Buy |
+555
| New | +$30.5K | ﹤0.01% | 2575 |
|
|
2016
Q1 | – | Sell |
-1,643
| Closed | -$74K | – | 3185 |
|
|
2015
Q4 | $74K | Sell |
1,643
-77
| -4% | -$3.23K | ﹤0.01% | 2499 |
|
|
2015
Q3 | $67K | Buy |
+1,720
| New | +$68.9K | ﹤0.01% | 2521 |
|
Other funds holding PRAH
Envestnet Asset Management's PRAH Position: Q3 2021 in Review
Envestnet Asset Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 15,175 shares — an estimated $2.51M sold.
Envestnet Asset Management first reported a position in PRAH in Q3 2015 and held it in 20 quarters. The position peaked at $3.19M in Q4 2019. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Envestnet Asset Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Envestnet Asset Management sold 15,175 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $2.51M.
- Envestnet Asset Management first reported a position in PRA Health Sciences, Inc. in Q3 2015 and held it in 20 quarters.
- Envestnet Asset Management's PRA Health Sciences, Inc. position peaked at $3.19M in Q4 2019.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Envestnet Asset Management's 13F filing for Q3 2021, filed 7 Oct 2021.